Introduction
============

MicroRNAs (miRNAs) are a highly conserved family of small, noncoding RNA species. In mammals, mature miRNAs are generated from primary miRNAs (pri-miRNAs) and precursor miRNAs (pre-miRNAs) via sequential processing by Drosha and Dicer and negatively regulate the expression of tumor suppressor genes and oncogenes via RNA interference. Therefore, miRNAs play an important role in various biological processes, including cell differentiation, proliferation, apoptosis, and metastasis.[@b1-ott-8-1859],[@b2-ott-8-1859] Recently, several studies have shown that miR-218 is downregulated in various types of cancer, including glioma, bladder cancer, lung cancer, and oral cancer.[@b3-ott-8-1859]--[@b6-ott-8-1859] The overexpression of miR-218 in cancer cells markedly suppresses invasion and proliferation and promotes apoptosis.[@b6-ott-8-1859]--[@b8-ott-8-1859]

Single-nucleotide polymorphism (SNP) is the most abundant form of DNA variation in the human genome. Common polymorphisms in miRNA genes, including pri-miRNAs, pre-miRNAs, and mature miRNAs, may alter various biological processes by influencing the processing and/or target selection of miRNAs.[@b9-ott-8-1859] A potential functional SNP (rs11134527, A \> G) of the putative promoter region of pre-miR-218 has been identified, and many studies from People's Republic of China have explored the association between rs11134527 polymorphism and susceptibility to cancer, including esophageal squamous cell carcinoma, hepatocellular carcinoma, and cervical cancer.[@b10-ott-8-1859]--[@b15-ott-8-1859] However, the results of these observations remain controversial and inconclusive. In the present study, we conducted a meta-analysis to derive a more precise and more comprehensive estimation of the associations.

Materials and methods
=====================

Publication search
------------------

We performed a publication search in the PubMed, Web of Science, and Chinese National Knowledge Infrastructure (CNKI) databases (up to March 27, 2015) with the following search terms: "pre-miR-218" or "rs11134527"; "cancer" or "carcinoma"; "genetic variation" or "polymorphism". Hand-searches were also performed to identify additional articles in the reference lists of included articles not retrieved by initial electronic search. All of the selected studies met the following criteria: 1) case-control study; 2) concerned the association between pre-miR-218 rs11134527 polymorphism and cancer risk in Chinese population; and 3) available genotype frequency.

Data extraction and quality assessment
--------------------------------------

Information was carefully reviewed and independently extracted from all the eligible articles by two investigators. The following items were collected: first author's name, year of publication, country of origin, genotyping method, source of the control groups (population- or hospital-based), total number of cases and controls, genotype distributions in the cases and controls, and *P*-value for Hardy--Weinberg equilibrium (HWE). If discrepancies and differences existed after data collection, discussion was carried out to get consensus.

Statistical analysis
--------------------

HWE in the controls was measured via chi-square test. The recessive model (GG versus GA + AA), dominant model (GG + GA versus AA), codominant model (GG versus AA, GA versus AA), and allelic model (G versus A) were used to assess the association between pre-miR-218 rs11134527 polymorphism and cancer risk in Chinese population. The strength of the association between the pre-miR-218 rs11134527 polymorphism and cancer risk in Chinese population was assessed using odds ratios (ORs) and 95% confidence intervals (CIs). The significance of the pooled OR was determined using the *z*-test and *P*~z~\<0.05 was considered statistically significant. Chi-square-based *Q* statistic and *I*^2^ statistic were conducted to evaluate heterogeneity between studies. If *P*~Q~\<0.05 or *I*^2^\>50%, the random-effects model was used to calculate the pooled OR. Otherwise, the fixed-effects model was selected. In order to evaluate the influence of each study on the overall estimate, we carried out sensitivity analysis by sequentially removing individual studies. Finally, the potential publication bias was tested by funnel plot. All analyses were performed in RevMan 5.0 software. All the tests were two-sided, and the significance level was less than 0.05.

Results
=======

Study selection and characteristics
-----------------------------------

Through the systematic literature search, six eligible studies containing 11,024 subjects (5,376 cancers cases and 5,648 controls) on the association between pre-miR-218 rs11134527 polymorphism and cancer risk in Chinese population are included in the present meta-analysis. The characteristics of each case-control study are summarized in [Table 1](#t1-ott-8-1859){ref-type="table"}. There were two case-control studies of esophageal squamous cell carcinoma, two of hepatocellular carcinoma, and two of cervical cancer. The genotype frequencies for the control group were all consistent with HWE in the included studies.

The pooled analysis
-------------------

The main results of pooled ORs for pre-miR-218 rs11134527 polymorphism and cancer risk in Chinese population are listed in [Table 2](#t2-ott-8-1859){ref-type="table"}. Overall, the pooled OR showed significant associations under the allelic model (G versus A, OR =0.93, 95% CI: 0.88--0.98), recessive model (GG versus AG + AA, OR =0.88, 95% CI: 0.79--0.97), and codominant model (GG versus AA, OR =0.85, 95% CI: 0.76--0.96) ([Figure 1](#f1-ott-8-1859){ref-type="fig"}). In the stratified analysis by cancer type, the pre-miR-218 rs11134527 polymorphism was only associated with the risk of cervical cancer (G versus A, OR =0.90, 95% CI: 0.83--0.98; GG versus AG + AA, OR =0.80, 95% CI: 0.68--0.94; GG versus AA, OR =0.79, 95% CI: 0.66--0.94).

Sensitivity analysis and publication bias
-----------------------------------------

Sensitivity analysis was performed to evaluate the stability of the results by removing one study at a time. We found that the estimated pooled ORs changed quite little, indicating that our results were statistically robust. Funnel plots were used to assess publication bias. As shown in [Figure 2](#f2-ott-8-1859){ref-type="fig"}, the shapes of the funnel plots seemed symmetrical, suggesting the absence of publication bias.

Discussion
==========

Genetic testing for cancer susceptibility has become a standard component of clinical practice over the last few years. Increasing evidence suggests that some SNPs play vital roles in the development of cancer.[@b16-ott-8-1859],[@b17-ott-8-1859] Some studies indicated that a potential functional SNP (rs11134527) in tumor-suppressive miR-218 was associated with the risk of cancer in Chinese population.[@b10-ott-8-1859],[@b11-ott-8-1859],[@b13-ott-8-1859],[@b15-ott-8-1859] In contrast, others showed that miR-218 rs11134527 polymorphism was not associated with cancer risk in Chinese population.[@b12-ott-8-1859],[@b14-ott-8-1859] Considering that previous studies from single centers and with small sample sizes may lack enough statistical power to assess the associations, we performed the meta-analysis with larger sample sizes. Results showed miR-218 rs11134527 polymorphism was associated with cancer risk in Chinese population. Furthermore, the stratified analysis based on cancer type suggested that pre-miR-218 rs11134527 polymorphism was only associated with the risk of cervical cancer.

There were some limitations in the current meta-analysis. First, these results are based on unadjusted estimates due to lack of original data from the eligible studies. In addition, only six studies were included in this meta-analysis. Thus, more studies are needed to identify this association more comprehensively.

Conclusion
==========

A significant association was found between the miR-218 rs11134527 polymorphism and cervical cancer risk in Chinese population. However, large-scale case-control and population-based studies involving potential gene--gene and gene--environment interactions are warranted to confirm our findings.

**Disclosure**

The authors report no conflicts of interest in this work.

![Forest plot of the association between pre-miR-218 rs11134527 polymorphism and cancer risk under GG versus AA.\
**Abbreviations:** CI, confidence interval; M--H, Mantel--Haenszel test.](ott-8-1859Fig1){#f1-ott-8-1859}

![Funnel plot of the association between pre-miR-218 rs11134527 polymorphism and cancer risk under GG versus AA.\
**Abbreviations:** OR, odds ratio; SE, standard error.](ott-8-1859Fig2){#f2-ott-8-1859}

###### 

General characteristics of studies included in the meta-analysis

  Authors                        Year   Country                      Cancer type       Source of controls   Detection   Sample size (cases/controls)   Cases   Controls   HWE                     
  ------------------------------ ------ ---------------------------- ----------------- -------------------- ----------- ------------------------------ ------- ---------- ----- ----- ----- ----- ------
  Zhang et al[@b12-ott-8-1859]   2014   People's Republic of China   ESCC              Population           SNaPshot    1,109/1,275                    396     529        184   454   630   191   0.25
  Jiang et al[@b10-ott-8-1859]   2014   People's Republic of China   ESCC              Hospital             PCR-LDR     706/745                        273     344        89    268   348   129   0.38
  Han et al[@b11-ott-8-1859]     2014   People's Republic of China   HCC               Hospital             qPCR        1,009/1,011                    372     470        167   336   493   182   0.96
  Shi et al[@b13-ott-8-1859]     2013   People's Republic of China   Cervical cancer   Hospital             TaqMan      1,565/1,391                    588     752        225   512   638   241   0.08
  Zhang et al[@b14-ott-8-1859]   2012   People's Republic of China   HCC               Hospital             PCR-RFLP    302/513                        88      170        44    165   269   79    0.07
  Zhou et al[@b15-ott-8-1859]    2010   People's Republic of China   Cervical cancer   Hospital             PCR-RFLP    685/713                        268     316        101   247   339   127   0.57

**Abbreviations:** ESCC, esophageal squamous cell carcinoma; HCC, hepatocellular carcinoma; HWE, Hardy--Weinberg equilibrium; PCR, polymerase chain reaction; PCR-LDR, PCR--ligase detection reaction; PCR-RFLP, PCR--restriction fragment length polymorphism; qPCR, quantitative PCR.

###### 

Meta-analysis of the pre-miR-218 rs11134527 polymorphism and cancer risk among Chinese population

  Variables          Allelic model (G versus A)            Dominant model (GG + GA versus AA)    Recessive model(GG versus AG + AA)                                                                                       
  ------------------ ------------------------------------- ------------------------------------- ------------------------------------ ------------------- ----- ------ ------ ------------------- ----- -------- -------- -------------------
  All                29%                                   0.22                                  0.01                                 0.93 (0.88--0.98)   0%    0.42   0.08   0.93 (0.86--1.01)   45%   0.11     0.01     0.88 (0.79--0.97)
  Cancer type                                                                                                                                                                                                             
   ESCC              73%                                   0.05                                  0.55                                 0.95 (0.79--1.14)   0%    0.42   0.49   0.95 (0.84--1.09)   86%   \<0.01   0.64     0.89 (0.55--1.44)
   Cervical cancer   0%                                    0.39                                  0.02                                 0.90 (0.83--0.98)   29%   0.23   0.18   0.92 (0.81--1.04)   0%    0.98     \<0.01   0.80 (0.68--0.94)
   HCC               34%                                   0.22                                  0.24                                 0.94 (0.84--1.04)   63%   0.10   0.81   0.97 (0.72--1.29)   0%    0.88     0.36     0.91 (0.75--1.11)
                     **Codominant model (GG versus AA)**   **Codominant model (GA versus AA)**                                                                                                                            
  All                39%                                   0.14                                  \<0.01                               0.85 (0.76--0.96)   0%    0.49   0.34   0.96 (0.88--1.04)                           
  Cancer type                                                                                                                                                                                                             
   ESCC              83%                                   0.02                                  0.58                                 0.87 (0.54--1.41)   0%    0.96   0.62   0.97 (0.84--1.11)                           
   Cervical cancer   0%                                    0.59                                  \<0.01                               0.79 (0.66--0.94)   35%   0.21   0.64   0.97 (0.85--1.10)                           
   HCC               0%                                    0.38                                  0.25                                 0.88 (0.70--1.10)   64%   0.10   0.91   0.98 (0.72--1.34)                           

**Abbreviations:** CI, confidence interval; ESCC, esophageal squamous cell carcinoma; HCC, hepatocellular carcinoma; OR, odds ratio; het, heterogeneity.
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